Giulio Cavalli
Overview
Explore the profile of Giulio Cavalli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
135
Citations
3781
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gaballa J, Falkesgaard Hojen J, de Graaf D, Amo-Aparicio J, Marchetti C, Cavalli G, et al.
Nat Immunol
. 2024 Mar;
25(4):581-582.
PMID: 38499798
No abstract available.
2.
Hoffmann M, Cavalli G, Fadle N, Cantoni E, Regitz E, Fleser O, et al.
J Clin Immunol
. 2024 Jan;
44(2):45.
PMID: 38231276
Background: Adult-onset Still's disease (AOSD) and systemic juvenile idiopathic arthritis (sJIA) resemble a continuum of a rare, polygenic IL-1β-driven disease of unknown etiology. Objective: In the present study we sought...
3.
Slavich M, Ricchetti G, Demarchi B, Cavalli G, Spoladore R, Federico A, et al.
J Cardiovasc Med (Hagerstown)
. 2023 Dec;
25(2):141-148.
PMID: 38149700
Background: Nearly two-thirds of patients with heart failure with reduced ejection fraction (HFrEF) have right ventricular dysfunction, previously identified as an independent predictor of reduced functional capacity and poor prognosis....
4.
Natalello G, Bosello S, Campochiaro C, Abignano G, De Santis M, Ferlito A, et al.
ACR Open Rheumatol
. 2023 Nov;
6(1):14-20.
PMID: 37916477
Objective: Systemic sclerosis (SSc) is an orphan disease that can lead to severe involvement of the gastrointestinal tract with a significant impact on patients' quality of life (QoL). The Mediterranean...
5.
Peyronel F, Haroche J, Campochiaro C, Pegoraro F, Amoura Z, Tomelleri A, et al.
Blood
. 2023 Oct;
142(24):2119-2123.
PMID: 37871575
This geoepidemiological study, performed in Italy and France, shows that Erdheim-Chester disease is increasingly diagnosed and cases cluster in specific geographic areas, namely southern Italy and central France. Disease frequency...
6.
Mastrangelo A, Monardo R, Galli L, Tomelleri A, Tassan Din C, Canetti D, et al.
Eur J Clin Microbiol Infect Dis
. 2023 Sep;
42(11):1383-1387.
PMID: 37723323
Management of COVID-19 patients experiencing persisting respiratory failure despite corticosteroids remains challenging. Data on high-dose intravenous anakinra (HD-ANK) in this context are lacking. We aimed to investigate the impact of...
7.
Rodriguez-Carrio J, Cavalli G, Gwinnutt J, Wieczorek M, Guillemin F, Verstappen S
RMD Open
. 2023 Aug;
9(3).
PMID: 37652556
Lifestyle factors (such as diet, physical activity or smoking habits, among others) are known to influence the progression of rheumatic and musculoskeletal diseases (RMDs). Despite contemporary improvements in RMD care,...
8.
Palmisano A, Campochiaro C, Vignale D, Tomelleri A, Luca G, Bruno E, et al.
Radiol Med
. 2023 Mar;
128(4):456-466.
PMID: 36947276
Purpose: Erdheim-Chester disease (ECD) is a rare multisystem histiocytosis, whose cardiovascular involvement has not been systematically characterized so far. We aimed to systematically (qualitatively and quantitatively) describe the features of...
9.
Rodriguez-Carrio J, Burska A, Conaghan P, Dik W, Biesen R, Eloranta M, et al.
RMD Open
. 2023 Mar;
9(1).
PMID: 36882218
Background: Type I interferons (IFN-I) contribute to a broad range of rheumatic and musculoskeletal diseases (RMDs). Compelling evidence suggests that the measurement of IFN-I pathway activation may have clinical value....
10.
Burska A, Rodriguez-Carrio J, Biesen R, Dik W, Eloranta M, Cavalli G, et al.
RMD Open
. 2023 Mar;
9(1).
PMID: 36863752
Objectives: To systematically review the literature for assay methods that aim to evaluate type I interferon (IFN-I) pathway activation and to harmonise-related terminology. Methods: Three databases were searched for reports...